Company
Sheatree Capital
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Link Cell Therapies | Series A | 2025-12-15 | |
| Outpace Bio | Series B Financing | 2024-08-01 | |
| RareCyte | Financing | 2024-06-27 | Lead |
Company
| Company | Round | Date | Lead |
|---|---|---|---|
| Link Cell Therapies | Series A | 2025-12-15 | |
| Outpace Bio | Series B Financing | 2024-08-01 | |
| RareCyte | Financing | 2024-06-27 | Lead |